BDRX Biodexa Pharmaceuticals Plc

$BDRX Buyer $BRDX at $.43 early am on 9-14. Reversal from near year low on DD & are T/A reasons. Buyer $YRD at $.71 on retrace in am to support . $BATL bottomed at support at price retest ready for reversal on more volume . War news will be pushing oil up all of 2026 on shortages in refined oil products Facts.

$BDRX nice swing, worth watching for tomorrow Biodexa completes enrollment of 100 patients in registrational Phase 3 Serenta trial of eRapa in FAP Company now expects planned futility analysis early next year, ahead of its prior timeline. Database lock for Serenta trial anticipated around year-end, also earlier than previously expected.

$BDRX oh maaaammma every day red? MTPism. Next R/S again ADR london old tutes doing their shix as usual.

Watching $BDRX Rs’d yesterday now its a 480k floater. Might get love from $NUWE todays rs runner

$BDRX Donnie will buy off this company with $360,000. And then do an offering and raise $1,000,000 worth of shares to the market and cash out $1,000,000 to my pocket and let this stock trash to zero lmao 🤣..lmao I’m dead hahahaha

$BDRX market cap $ 360,000 !!!??????????? wtf 😳 hahahah , I can literally buy this company off lmao .. wth is this a joke ??? lol 😂

$BDRX brokerage account showing MCap went from $600K earlier this week to $2.3M today, diluting shares here 🤨 still adding these levels. MM’s trying to push it lower but at some point shorts will get trapped badly here

$BDRX easiest short of your life Over and over and over again It’s like Mo guaranteed big moola

TAKE SOME OF THOSE PROFITS AND PUT THEM TO WORK IN MCRB. Seres Therapeutics is sitting at an incredibly oversold level, with RSI under 20 and the stock trading near all-time historic lows. Quite frankly, I think this is one of the most compelling risk/reward opportunities in small-cap biotech right now. SER-155. irEC. Allo-HSCT. Multiple pipeline programs. Potential partnerships. Strategic possibilities. And at this valuation, the market is pricing in an enormous amount of failure. I firmly believe we’ll see some kind of meaningful update in October or, at the latest, early November. 👀 If you’re sitting on profits in $BDRX ,$LQDA , $TCRT or elsewhere, consider taking a little off the table and putting it into MCRB. I’m not saying go all-in. I’m saying look at the setup. You can thank me later. 😂🐂

$BDRX keep watch on breaking out past .60, if we have enough juice to clear.72 we may hit $1, and Fomo could do more. Support .46-.47

$BDRX running overnight! Why aren’t more people seeing this lol I guess we’re early to the party

$BDRX — Biodexa Pharmaceuticals' Serenta trial progress and technical downtrend were central to recent analyses. Recent analyses for Biodexa Pharmaceuticals (BDRX) covered the company's progress in its Phase 3 Serenta trial for Familial Adenomatous Polyposis (FAP), including reaching a 100-patient enrollment milestone and an accelerated timeline for analysis. The reports also detailed the company's financial performance, noting consistent net losses and negative gross profits, alongside a strong current ratio and zero total debt. Technical indicators were examined, showing a significant downtrend with the stock trading below key moving averages, though some short-term indicators presented mixed signals.

$BDRX working at 6660 Financial Dr. today installing a stretch wrapper. Let's stretch that PT to .666 today and next week will be a wrap on all financial worries! Happy Friday, worked shutdowns over Thanksgiving so finally some time to relax!

$BDRX So, to those who have been here, are we concerned about the 1:8 RS 10-26? Or do we think management will cancel it once this runs to $3 tomorrow lol

$BDRX man, be cool if she roxkets and they don t have to do r/s. Still, 1-8 is hella good. Way better than 1-250 lolz

$BDRX Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP

$BDRX 500% Short market requirement. 270K shares short. 300%-800% CTB over the last month. Hovered around 80% before that. For that 270K @ around .66 is $178K short, you'd need almost $900K cash in your margin account to do so.... Costing over $2K a day in fees. 60 trading days at those metrics and your whole short position is now what you've paid in fees.

$BDRX 524k float ( speciality when run , run like crazy) $ZBAO 8.8M float beaten down ( specialty same , when run , run like crazy)

$BDRX I suspect AH could be fun with this opening pump showing up. SI report comes out on Monday, same day as the RS. Something fishy has been going on... Currently shows 18K shares short and over 150K available yet CTB has stayed above 200% for all but a brief period since April. Been over half a year which would mean any short (if there are any) has paid a lot to try and keep their position in the shadows.

🚨 **THE FIRST OF MANY CATALYSTS TO COME?** 🚨 Today's SER-428 update is another reminder that Seres has a pipeline the market is assigning virtually ZERO value to. TAKE SOME OF THOSE PROFITS AND PUT THEM TO WORK IN MCRB. Seres Therapeutics is sitting at an incredibly oversold level, with RSI under 20 and the stock trading near all-time historic lows. Quite frankly, I think this is one of the most compelling risk/reward opportunities in small-cap biotech right now. SER-155. irEC. Allo-HSCT. Multiple pipeline programs. Potential partnerships. Strategic possibilities. And at this valuation, the market is pricing in an enormous amount of failure. I firmly believe we’ll see some kind of meaningful update in October or, at the latest, early November. 👀 If you’re sitting on profits in $BDRX , $LQDA , $TCRT or elsewhere, consider taking a little off the table and putting it into MCRB. I’m not saying go all-in. I’m saying look at the setup. You can thank me later.💰